Hims & Hers Health (HIMS) Capital Expenditures (2020 - 2026)
Hims & Hers Health's (HIMS) quarterly Capital Expenditures came in at $8.8 million in Q1 2026, down 84.04% year-on-year from $55.3 million in Q1 2025, and up 96.48% quarter-over-quarter from $4.5 million in Q4 2025.
Hims & Hers Health (HIMS) Capital Expenditures (2020 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Capital Expenditures across 7 years of filings, most recently posting $8.8 million for Q1 2026.
- Capital Expenditures for Q1 2026 came in at $8.8 million, down 84.04% year-over-year; the trailing twelve-month figure through Mar 2026 was -$30.0 million (down 150.15% YoY), and the FY2025 annual result was $16.5 million, up 112.65% from the prior year.
- Capital Expenditures came in at $8.8 million for Q1 2026 at Hims & Hers Health, up from $4.5 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $55.3 million in Q1 2025 to a low of -$38.4 million in Q2 2025.
- The 5-year median for Capital Expenditures is $2.8 million (2023), against an average of $3.4 million.
- Peak annual rise in Capital Expenditures reached 1538.35% in 2025, while the deepest fall reached 1709.19% in 2025.
- Hims & Hers Health's Capital Expenditures stood at -$1.2 million in 2022, then soared by 821.05% to $8.6 million in 2023, then slumped by 111.0% to -$949000.0 in 2024, then jumped by 573.45% to $4.5 million in 2025, then surged by 96.48% to $8.8 million in 2026.
- The last three Capital Expenditures figures came in at $8.8 million (Q1 2026), $4.5 million (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 8.83 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 6.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.83 Mn |
| Mar 31, 2026 | 8.83 Mn |
| Dec 31, 2025 | 4.49 Mn |
| Dec 31, 2025 | 4.49 Mn |
| Sep 30, 2025 | -4.90 Mn |
| Sep 30, 2025 | -4.90 Mn |
| Jun 30, 2025 | -38.37 Mn |
| Jun 30, 2025 | -38.37 Mn |
| Mar 31, 2025 | 55.33 Mn |
| Mar 31, 2025 | 55.33 Mn |
| Dec 31, 2024 | -949,000.00 |
| Dec 31, 2024 | -949,000.00 |
| Sep 30, 2024 | 7.47 Mn |
| Sep 30, 2024 | 7.47 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | 3.38 Mn |
| Mar 31, 2024 | 3.38 Mn |
| Dec 31, 2023 | 8.63 Mn |
| Dec 31, 2023 | 8.63 Mn |